These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19130408)

  • 1. Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer.
    Zardawi SJ; O'Toole SA; Sutherland RL; Musgrove EA
    Histol Histopathol; 2009 Mar; 24(3):385-98. PubMed ID: 19130408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
    Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
    Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung squamous cell carcinoma and lung adenocarcinoma differential gene expression regulation through pathways of Notch, Hedgehog, Wnt, and ErbB signalling.
    Anusewicz D; Orzechowska M; Bednarek AK
    Sci Rep; 2020 Dec; 10(1):21128. PubMed ID: 33273537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt/Hedgehog/Notch pathways.
    Kikuchi I; Takahashi-Kanemitsu A; Sakiyama N; Tang C; Tang PJ; Noda S; Nakao K; Kassai H; Sato T; Aiba A; Hatakeyama M
    Nat Commun; 2016 Sep; 7():12887. PubMed ID: 27650679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Signal pathways in breast cancer stem cells and the targeted stem cell therapy].
    Ma Y; Wang HX
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):881-5. PubMed ID: 21223793
    [No Abstract]   [Full Text] [Related]  

  • 6. Ciliary signalling in cancer.
    Liu H; Kiseleva AA; Golemis EA
    Nat Rev Cancer; 2018 Aug; 18(8):511-524. PubMed ID: 29802351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huaier aqueous extract inhibits stem-like characteristics of MCF7 breast cancer cells via inactivation of hedgehog pathway.
    Wang X; Zhang N; Huo Q; Sun M; Dong L; Zhang Y; Xu G; Yang Q
    Tumour Biol; 2014 Nov; 35(11):10805-13. PubMed ID: 25077927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch.
    Bertrand FE; Angus CW; Partis WJ; Sigounas G
    Cell Cycle; 2012 Dec; 11(23):4344-51. PubMed ID: 23032367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Notch intracellular domain integrates signals from Wnt, Hedgehog, TGFβ/BMP and hypoxia pathways.
    Borggrefe T; Lauth M; Zwijsen A; Huylebroeck D; Oswald F; Giaimo BD
    Biochim Biophys Acta; 2016 Feb; 1863(2):303-13. PubMed ID: 26592459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel signal transduction pathways: the molecular basis for targeted cancer therapies in Hedgehog/Notch/Wnt pathway].
    Shimizu T; Nakagawa K
    Nihon Rinsho; 2015 Aug; 73(8):1342-8. PubMed ID: 26281688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications.
    Patni AP; Harishankar MK; Joseph JP; Sreeshma B; Jayaraj R; Devi A
    Cell Oncol (Dordr); 2021 Jun; 44(3):473-494. PubMed ID: 33704672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of WNT2B based on the balance of Hedgehog, Notch, BMP and WNT signals.
    Katoh M; Katoh M
    Int J Oncol; 2009 May; 34(5):1411-5. PubMed ID: 19360354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting embryonic signaling pathways in cancer therapy.
    Harris PJ; Speranza G; Dansky Ullmann C
    Expert Opin Ther Targets; 2012 Jan; 16(1):131-45. PubMed ID: 22239436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targets of triple-negative breast cancer: a review.
    Jamdade VS; Sethi N; Mundhe NA; Kumar P; Lahkar M; Sinha N
    Br J Pharmacol; 2015 Sep; 172(17):4228-37. PubMed ID: 26040571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell epigenetics and chemoresistance.
    Crea F; Danesi R; Farrar WL
    Epigenomics; 2009 Oct; 1(1):63-79. PubMed ID: 22122637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.
    Takebe N; Harris PJ; Warren RQ; Ivy SP
    Nat Rev Clin Oncol; 2011 Feb; 8(2):97-106. PubMed ID: 21151206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.
    Kakarala M; Wicha MS
    J Clin Oncol; 2008 Jun; 26(17):2813-20. PubMed ID: 18539959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cancer stem cells in the anti-carcinogenicity of curcumin.
    Norris L; Karmokar A; Howells L; Steward WP; Gescher A; Brown K
    Mol Nutr Food Res; 2013 Sep; 57(9):1630-7. PubMed ID: 23900994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of colorectal cancer.
    Saif MW; Chu E
    Cancer J; 2010; 16(3):196-201. PubMed ID: 20526096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hedgehog signalling pathway as a therapeutic target in early breast cancer development.
    O'Toole SA; Swarbrick A; Sutherland RL
    Expert Opin Ther Targets; 2009 Sep; 13(9):1095-103. PubMed ID: 19659449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.